TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04758897 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT04328389 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05745714 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study NCT05012644 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05012644 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04989361 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06205121 — Predictive Biomarker (PRD): CHIT1 mRNA
Genes: CHIT1
Study NCT04399421 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05027828 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06639789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05789251 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT06644742 — Predictive Biomarker (PRD): PKP2 mRNA
Genes: PKP2
Study NCT04994977 — Predictive Biomarker (PRD): ACP3 mRNA
Genes: ACP3; ACPP
Study NCT04488289 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06085079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06460272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06720350 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06719856 — Predictive Biomarker (PRD): MMP14 mRNA
Genes: MMP14
Study NCT06716580 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06716580 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06262542 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06262542 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00010478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05529589 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06149169 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05737979 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04908644 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04955548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05010590 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05511948 — Predictive Biomarker (PRD): DBI mRNA
Genes: DBI
Study NCT06546527 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05839938 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05005819 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT05005819 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06006104 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05734196 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT05734196 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT04518137 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT04518137 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT04518137 — Predictive Biomarker (PRD): RICTOR mRNA
Genes: RICTOR; KIAA1999
Study NCT05222178 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06341894 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06341894 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04828486 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT04958057 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05630131 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06005402 — Predictive Biomarker (PRD): NKX2-5 mRNA
Genes: NKX2-5; CSX; NKX2.5; NKX2E
Study NCT06479356 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05363592 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05210725 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06583512 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05329220 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05228158 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT04512716 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05046587 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04997902 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT04997902 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04997902 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05974644 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06097429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06553222 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00501358 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05391776 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05739448 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06393751 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT06715228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05857306 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT05042921 — Predictive Biomarker (PRD): Chromosome 5q
Study NCT05077423 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04893980 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00002325 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05982093 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05982093 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06175923 — Predictive Biomarker (PRD): TWIST1 mRNA
Genes: TWIST1; BHLHA38; TWIST
Study NCT06175923 — Predictive Biomarker (PRD): BMP2 mRNA
Genes: BMP2; BMP2A
Study NCT06175923 — Predictive Biomarker (PRD): BMP4 mRNA
Genes: BMP4; BMP2B; DVR4
Study NCT06489067 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT06489067 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06489067 — Predictive Biomarker (PRD): LZTR1 mRNA
Genes: LZTR1; TCFL2
Study NCT06489067 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT06489067 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT06489067 — Predictive Biomarker (PRD): MRAS mRNA
Genes: MRAS; RRAS3
Study NCT06489067 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06489067 — Predictive Biomarker (PRD): PPP1CB mRNA
Genes: PPP1CB
Study NCT06489067 — Predictive Biomarker (PRD): PTPN11 mRNA
Genes: PTPN11; PTP2C; SHPTP2
Study NCT06489067 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06489067 — Predictive Biomarker (PRD): RIT1 mRNA
Genes: RIT1; RIBB; RIT; ROC1
Study NCT06489067 — Predictive Biomarker (PRD): RRAS2 mRNA
Genes: RRAS2; TC21
Study NCT06489067 — Predictive Biomarker (PRD): SOS1 mRNA
Genes: SOS1
Study NCT06113861 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04985058 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04985058 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06478862 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06478862 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06478862 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT06478862 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT06560333 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06635785 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06043817 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06043817 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06058091 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06223529 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT04847947 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT04847947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06079983 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05573711 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT04744584 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05735444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05296161 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04603183 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04603183 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04891029 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT06019481 — Predictive Biomarker (PRD): OTOF mRNA
Genes: OTOF; FER1L2
Study NCT06019481 — Predictive Biomarker (PRD): GJB2 mRNA
Genes: GJB2
Study NCT06019481 — Predictive Biomarker (PRD): GJB6 mRNA
Genes: GJB6
Study NCT06140251 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05334836 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04924075 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT05036135 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05036135 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05384132 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06597019 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06597019 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06249919 — Predictive Biomarker (PRD): TAFA5 mRNA
Genes: TAFA5; FAM19A5; UNQ5208/PRO34524
Study NCT05442697 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT06715748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06750094 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06750094 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06479239 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06479239 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05024344 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study NCT06405633 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05937919 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05853198 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00001063 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05790447 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04812327 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06631976 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06631976 — Safety Biomarker (SAF): BDNF
Study NCT05067335 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05677880 — Predictive Biomarker (PRD): NOTCH3 mRNA
Genes: NOTCH3
Study NCT05677880 — Predictive Biomarker (PRD): NOTCH2 mRNA
Genes: NOTCH2
Study NCT05962021 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05962021 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05786287 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04679454 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04863430 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04773665 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04675827 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04675827 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05099263 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study NCT04843059 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04843059 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study NCT06321913 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05964686 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05478772 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05478772 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT05041829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06495424 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study NCT00000871 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05589909 — Predictive Biomarker (PRD): IL27 mRNA
Genes: IL27; IL27A; IL30
Study NCT05589909 — Predictive Biomarker (PRD): IL27
Genes: IL-27; p28; IL27p28; IL-27A; IL27A; MGC71873
Study NCT00002079 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04931108 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05223673 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05223673 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05223673 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04576494 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04576494 — Predictive Biomarker (PRD): Chromosome 5q
Study NCT06703944 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT06703944 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05638828 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT06414668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04983745 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT06161051 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05683379 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04275804 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05574881 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05574881 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04714593 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04714593 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04714593 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05520684 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06306001 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT05355415 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT04862754 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06156150 — Predictive Biomarker (PRD): ATF3 mRNA
Genes: ATF3
Study NCT06156150 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT06156150 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT06062303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06163131 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06377150 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT04956224 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05998525 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04742842 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06118658 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT06118658 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT06555146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05243602 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05441514 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT04858581 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04655157 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05785208 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05785208 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04867018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04867018 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05879978 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study NCT06503497 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT06222203 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06222203 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT04419181 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05493410 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06171061 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT05781581 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05148780 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05279898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04710017 — Predictive Biomarker (PRD): PALM mRNA
Genes: PALM; KIAA0270
Study NCT06204484 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06594705 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05779930 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06715358 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06717711 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT04722094 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04800224 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05975242 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06188962 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT06032884 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05804604 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT05804604 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT05538988 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04770935 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05421234 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06250465 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06102395 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04186585 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT05307666 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06461637 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05242289 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT06441279 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05697718 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06183398 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05286333 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT04415333 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04911049 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06528405 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05173597 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06280209 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06254066 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06254066 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05388578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05302713 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06486883 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06486883 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06486883 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06486883 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06410521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05171998 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05160883 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT06274658 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05638620 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05193448 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05431595 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT06405555 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06405555 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06415487 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06415487 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04644185 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05595928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06460948 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06040541 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05556902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04551469 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05411497 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT06650384 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05796440 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT06622005 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06440252 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06717139 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06717139 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04470024 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study NCT05812885 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT04671719 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study NCT04671719 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study NCT05904028 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD